Burska et al., 2013 - Google Patents
Deubiquitinating enzyme Usp12 is a novel co-activator of the androgen receptorBurska et al., 2013
View HTML- Document ID
- 4407343482572454631
- Author
- Burska U
- Harle V
- Coffey K
- Darby S
- Ramsey H
- O'Neill D
- Logan I
- Gaughan L
- Robson C
- Publication year
- Publication venue
- Journal of Biological Chemistry
External Links
Snippet
The androgen receptor (AR), a member of the nuclear receptor family, is a transcription factor involved in prostate cell growth, homeostasis, and transformation. AR is a key protein in growth and development of both normal and malignant prostate, making it a common …
- 108010080146 androgen receptors 0 title abstract description 225
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Burska et al. | Deubiquitinating enzyme Usp12 is a novel co-activator of the androgen receptor | |
Wang et al. | The diverse roles of SPOP in prostate cancer and kidney cancer | |
Liu et al. | Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer | |
Qin et al. | BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5 | |
Geng et al. | SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein | |
Liao et al. | Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor | |
Kim et al. | Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis | |
Kim et al. | Functional regulation of Slug/Snail2 is dependent on GSK‐3β‐mediated phosphorylation | |
Nassour et al. | Peroxiredoxin 1 interacts with and blocks the redox factor APE1 from activating interleukin-8 expression | |
Kang et al. | Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor | |
Janghorban et al. | Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer | |
Mungamuri et al. | USP7 enforces heterochromatinization of p53 target promoters by protecting SUV39H1 from MDM2-mediated degradation | |
Lakhal et al. | Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis | |
Loignon et al. | Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy | |
Fiskus et al. | SIRT2 deacetylates and inhibits the peroxidase activity of peroxiredoxin-1 to sensitize breast cancer cells to oxidant stress-inducing agents | |
Sun et al. | A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants | |
Richmond et al. | The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells | |
Li et al. | A Feedback Loop between the Androgen Receptor and a NEDD4-binding Protein, PMEPA1, in Prostate Cancer Cells∗ | |
Liu et al. | Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis | |
Asim et al. | Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase | |
Wang et al. | The role of TXNDC5 in castration-resistant prostate cancer—Involvement of androgen receptor signaling pathway | |
Wen et al. | Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil–induced apoptosis of A549 cells | |
Xuan et al. | Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1 | |
McClurg et al. | Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway | |
Link et al. | Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity |